Adipogenic Differentiation of Human Adult Stem Cells From Bone Marrow Stroma (MSCs)
Top Cited Papers
- 1 February 2004
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 19 (2) , 256-264
- https://doi.org/10.1359/jbmr.0301220
Abstract
We assayed gene expressions during adipogenesis of human MSCs. Microarray assays demonstrated time-dependent increases in expression of 67 genes, including 2 genes for transcription factors that were not previously shown to be expressed during adipogenesis. INTRODUCTION Increased numbers of bone marrow adipocytes have been observed in patients with osteoporosis and aplastic anemia, but the pathological mechanisms remain unknown. Recently, microarray assays for mRNAs were used to follow adipogenic differentiation of the preadipocytic cell line, 3T3-L1, but adipogenic differentiation has not been examined in primary cells from bone marrow. Here we defined the sequence of gene expression during the adipogenesis ex vivo of human cells from bone marrow referred to as either mesenchymal stem cells or marrow stromal cells (MSCs). MSCs were plated at extremely low densities to generate single-cell derived colonies, and adipogenic differentiation of the colonies assayed by accumulation of fat vacuoles, time-lapse photomicroscopy, microarrays, and reverse transcriptase-polymerase chain reaction (RT-PCR) assays. RESULTS AND CONCLUSIONS About 30% of the colonies differentiated to adipocytes in 14 days and about 60% in 21 days. Cell proliferation was inhibited by approximately 50% in adipogenic medium. The differentiation occurred primarily at the center of the colonies, and a few adipocytes that formed near the periphery migrated toward the centers. RT-PCR assays demonstrated that the differentiation was accompanied by increases in a series of genes previously shown to increase with adipogenic differentiation: peroxisome proliferator activated receptor gamma, CCAAT enhancer-binding protein alpha, acylCoA synthetase, lipoprotein lipase, and fatty acid binding protein 4. We also followed differentiation with microarray assays. Sixty-seven genes increased more than 10-fold at day 1 and 20-fold at day 7, 14, or 21. Many of the genes identified were previously shown to be expressed during adipocytic differentiation. However, others, such as zinc finger E-box binding protein and zinc finger protein 145, were not. This study should serve as a basis for future study to clarify the mechanisms of adipocyte differentiation of MSCs.Keywords
This publication has 36 references indexed in Scilit:
- Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields of Early Progenitors and Evaluate Their QualityThe International Journal of Cell Cloning, 2002
- Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor α in Adipocyte MetabolismMolecular and Cellular Biology, 2002
- Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritisArthritis & Rheumatism, 2002
- The Transcriptional Repressor ZEB Regulates p73 Expression at the Crossroad between Proliferation and DifferentiationMolecular and Cellular Biology, 2001
- Assessment of Gene Regulation by Bone Morphogenetic Protein 2 in Human Marrow Stromal Cells Using Gene Array TechnologyJournal of Bone and Mineral Research, 2001
- An Essential Regulator of Adipogenesis and Modulator of Fat Cell Function: PPARγCell, 1999
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Human Trabecular Bone Cells Are Able to Express Both Osteoblastic and Adipocytic Phenotype: Implications for Osteopenic DisordersJournal of Bone and Mineral Research, 1998
- Development and characterization of a conditionally transformed adult human osteoblastic cell lineJournal of Bone and Mineral Research, 1996
- Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.Journal of Clinical Investigation, 1993